(Qiagen). cDNA synthesis, and hybridization to Affymetrix Human Genome U133 Plus 2.0 Arrays were performed as described previously (Signoretti et al., 2002; Wang et al., 2004) .
Array Analysis
The microarray raw data was deposited to public database (NCBI-Gene Expression Omnibus, accession number: GSE6885, NCBI tracking system #15246524).
Comparisons between cell lines (Figures 6 A,B , D, Figure S7 ) was performed using 21 Affymetrix HG-U133 Plus 2 microarrays (4-6 biological replicates per cell type) were preprocessed and normalized with GeneChip Robust Multi-Array Analysis (GCRMA) (Wu and Irizarry, 2005) . Absent/Present calls were made using 'affy' from BioConductor, and probe sets that were Absent or Marginal across all chips were removed from further analysis. Differential expression (DE) was defined as greater that 2-fold difference in expression level for each pairwise comparison. Probe set annotations were obtained from the Affymetrix web site, but regardless of annotation, all probe sets were used for the analysis, including poorly annotated sequences and duplicates for some genes. After classification based on DE and sorting by expression ratio, profiles were visualized as heatmaps with Java TreeView (Saldanha 2004) using the log2 ratios of RNA levels of each cell type compared to the mean across all cell types.
To verify statistical significance of expression patterns obtained in Figure 6 , 16 Affymetrix HG-U133 Plus 2 microarrays (4 biological replicates per cell type) were preprocessed and normalized with GeneChip Robust Multi-Array Analysis (GCRMA) (Wu et al., 2005) . Differential expression was determined via a modified t-test (p<0.05) using Linear Models for Microarray Data (Smyth 2004 ) and correcting for False Discovery Rate.
Unsupervised hierarchical cluster analysis ( Figure S6 ) was performed using dChip hierarchical cluster function with a set of genes filtered for significant variation of expression across the sample set (standard deviation/mean expression values between 0.8 and 10). Only probe sets with RefSeq validation and annotation were used in the analyses. Duplicate probes for the same gene were excluded. (Matros et al., 2005; Wang et al., 2004) . Raw expression data obtained using Affymetrix GENECHIP software was normalized and analyzed using DNA-Chip Analyzer (dChip) custom software (Wong, W.H., Li, C. http://www.dChip.org). Array probe data was normalized to the mean expression level of each probe across the combined human tumor and cell line sample set. (Matros et al., 2005; Richardson et al., 2006) . Figure S1 . Selection of distinct subpopulations of mammary epithelial cells with differing growth medium and attachment requirements (A) Transfer of primary BPE cells that had been grown in WIT medium and on tissue culture plates with a modified attachment surface (Primaria) during the initial three weeks of in vitro culture (left) into MEGM medium and on regular tissue culture plastic resulted in rapid senescence of the entire cell population within 5 -7 days (right, bar = 10 micrometer).
(B)Transfer of primary BPE cells that had been grown in WIT medium and on tissue culture plates with a modified attachment surface (Primaria) during the initial three weeks of in vitro culture (left) onto tissue culture plates with a regular plastic attachment surface in WIT medium resulted in rapid death of the entire cell population within 48h (right, bar = 10 micrometer).
(C) Transfer of primary HME cells that had been grown in MEGM medium and on regular plastic during the initial three weeks of in vitro culture (left) into WIT medium and on Primaria plates resulted in rapid death of the entire cell population within 24 -48h (right, bar = 25 micrometer). Figure S2 . Derivation of tumorigenic human mammary epithelial cells with defined genetic elements (A) Comparison of luminal-and myoepithelial-specific expression signatures with genes that are differentially expressed ≥2-fold between untransformed BPEC-hTERT and HMEC-hTERT populations. Each bar represents the number of luminal or myoepithelial-specific transcripts expressed at a higher level (≥2-fold) in one cell type relative to the other: open bar (luminalspecific genes), filled bar (myoepithelial-specific genes). The mRNA from BPEC-hTERT and HMEC-hTERT populations derived from three different individuals was analyzed, and compared to luminal-vs. myoepithelial-specific gene expression profile that has been identified previously (Grigoriadis et al., 2006) . A full list of genes that are differentially expressed between BPECs and HMECs, and the list of genes that correspond to each specific bar in this figure is available in Table S3 .
Supplemental Figure 1
(B) BPECs and HMECs were transformed in three separate consecutive steps using retroviral vectors expressing hTERT, SV40 early region expressing Large-T and small-t proteins (SV40 ER) and H-ras, as previously described (Elenbaas et al., 2001; Hahn et al., 1999) . BPEC (primary cells), BPE (untransformed hTERT-expressing cells), BPLE (hTERT + SV-40 ER transformed, non-tumorigenic cells), BPLER (hTERT +SV-40 ER+ H-Ras transformed tumorigenic cells).
(C) Southern blot of polyclonal BPLER population and single cell-derived BPLER clones. Genomic DNA from the polyclonal BPLER population (lane 1) and a single-cell-derived BPLER clone (lane 2) were both digested with NDE-I and probed with pBABE-puro-ras plasmid that was 32 P-labeled with a random prime labeling system. The presence of a single band in the single cell-derived clone confirms low infection multiplicity. Southern blot analyses of other single-cell-derived clones also showed low number of integration sites (mostly 1-3 integration sites per vector in each infected cell). The presence of a strong merged specific signal extending between ~0.3 and 2.0 Kb in lane 1 confirmed that BPLER cell population is highly polyclonal.
(D) Southern blots of hTERT-immortalized BPECS and their fully transformed tumorigenic BPLER derivatives. Southern blot of genomic DNA from control BPECs with no retroviral vector expression (lane 1), BPE cells that express gfp-hTERT only (lane 2), and tumorigenic BPLER cells that express all three vectors (lane 3). The genomic DNA was digested with BamHI and was probed with pmig-GFP-hTERT plasmid that was 32 P-labeled with a random prime labeling system. The presence of numerous different size bands illustrated that BPLER cells remained polyclonal throughout multiple steps of transformation; most of the bands that were present after introduction of hTERT in BPE cells were are still present in similar ratios in fully transformed and tumorigenic BPLER cells that had gone through two additional steps of retroviral infection and selection, confirming the absence of in vitro selection of rare clones during the transformation process. The BPLER xenograft tumors contained poorly differentiated areas (A) with highly infiltrative cells that invaded adjacent skeletal muscle (B).
Immunohistochemical staining of BPLER tumors highlights well-differentiated epithelial ductal structures that express cytokeratin 8/18 (C), and a strongly SMA-positive desmoplastic response (D). A double immunostain for Large T-Ag (red) and α-SMA (brown) highlights all the BPLER tumor cell nuclei (red) and mouse myofibroblasts (brown). The mutually exclusive staining pattern of the two markers confirms that SMA is expressed by stromal non-neoplastic cells only, and not by BPLER cells (E). Immunohistochemical staining for estrogen receptor (F), progesterone receptor (G) and Her2 (H) showed focal weak staining in less than 1-5 % of the tumor cells in occasional BPLER tumors. This low level of staining would be categorized as (ER/PR/HER2) triple-negative according to current diagnostic criteria used for histopathological and clinical classification of human breast tumors. HMLER tumors were completely negative for these three marker (bar= 100 micrometer). mRNA from HMEC-hTERT, HMLER, BPEC-hTERT, BPLER cells that were grown in WIT or MEGM medium in parallel for 10 days was examined. Both tumorigenic cell types, HMLER and BPLER, co-clustered based on cell type rather than the medium type they were propagated in. This result suggests that the gene expression differences between BPLER and HMLER are not readily altered upon change in growth conditions from MEGM medium into WIT medium. BPEC-hTERT cells could not be propagated in MEGM medium and thus are not included in this analysis. Each column represents a single cell type grown in a different medium; and each row represents a different gene. Clustering orders the samples according to greatest similarity of gene expression, shown by the dendrograms at the top, and orders genes by similarity of expression level among the sample set, shown by the dendrograms along the side. Relative gene expression levels are represented as follows: mean expression in white, expression above the mean in shades of red, expression below the mean in shades of blue. The genes with mRNA expression levels that change ≥2-fold upon transformation in HME vs. HMLER but not in BPE vs. BPLER (n= 4184).
In vitro transformation induced changes that are cell-type-independent;
c) The genes with concordant ≥ 2-fold mRNA expression level change with transformation in both BPECs and HMECs (n= 987). The genes with greater than or equal to 2-fold difference in their mRNA expression level between tumorigenic vs. tumorigenic cells (BPLER / HMLER) but not between the normal cell origin (BPE / HME) (n=3487 genes).
